Baisong Mei

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Cambridge, MA
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Baisong Mei

Form 4 holding EVP, CHIEF MEDICAL OFFICER

Editas Medicine, Inc.

Security class
Common Stock
Shares / value
133,354
Estimated value
$277,003
Report date
03 Dec 2024
Price
$2.08
Ownership
Direct
Form 4 holding Chief Medical Officer

CITY THERAPEUTICS, INC.

Security class
Common Stock
Shares / value
228,743
Estimated value
Report date
15 Oct 2026
Price
Ownership
Direct
Form 4 holding EVP, CHIEF MEDICAL OFFICER

Editas Medicine, Inc.

Security class
Stock Option (right to buy)
Shares / value
152,800
Estimated value
Report date
02 Mar 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Baisong Mei

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .